
Cement augmentation of PFNA for trochanteric fracture has no significant effect on early function

Cement augmentation of PFNA for trochanteric fracture has no significant effect on early function
Cement augmentation of the Proximal Femoral Nail Antirotation (PFNA) - A multicentre randomized controlled trial
Injury. 2018 Aug;49(8):1436-1444. doi: 10.1016/j.injury.2018.04.022Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
253 patients scheduled for intramedullary nailing of a trochanteric fracture with the Proximal Femoral Nail Antirotation helical blade implant (PFNA; DePuy) were randomized to either receive or not receive additional cement augmentation of the device. The primary outcome was the functional performance on the Timed Up and Go test, while secondary outcomes included mobility and activities of daily l...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.